Armata Pharmaceuticals

Founded with a mission to combat antibiotic resistance, Armata Pharmaceuticals is a biotechnology company focused on developing innovative phage therapeutics. Their core vision is to provide high-impact, best-in-class solutions for diagnosing, treating, and preventing human and animal diseases. Armata's primary market focus is on addressing the global health challenge posed by antibiotic-resistant infections through precision-engineered bacteriophage therapies.

Notable figures affiliated with Armata Pharmaceuticals include leading scientists and biotech investors committed to advancing phage therapy research. The company has achieved significant milestones in preclinical and clinical development, positioning itself as a pioneer in the field of bacteriophage-based treatments. Armata's impact is marked by its contributions to the scientific community and its potential to revolutionize the treatment of antibiotic-resistant infections, offering hope for more effective and targeted therapies.